About Qianglian Zhichuang
Qianglian Zhichuang is a company based in Beijing (China) founded in 2016 by Qin Tong. Qianglian Zhichuang operates in a competitive market with competitors including Artrya, PrediSurge, Saigeware Technologies, Topspin Medical and x-cardiac, among others.
- Headquarter Beijing, China
- Founders Qin Tong
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Sequoia Capital
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Qianglian Zhichuang
Investors in Qianglian Zhichuang
Qianglian Zhichuang has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Sequoia Capital, Poly Development Holdings and BioTrack Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
BioVenture is focused on early and growth-stage healthcare investments.
|
Locked | Locked | Locked |
Investor details for Qianglian Zhichuang
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Qianglian Zhichuang
Investment portfolio details for Qianglian Zhichuang
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Qianglian Zhichuang
Detailed financials for Qianglian Zhichuang
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Qianglian Zhichuang Comparisons
Peer comparison for Qianglian Zhichuang
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Qianglian Zhichuang
Qianglian Zhichuang operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Artrya, PrediSurge, Saigeware Technologies, Topspin Medical and x-cardiac, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based cardiovascular analysis tools are provided to healthcare providers.
|
|
| Locked | Locked | Locked |
Provider of decision making tools for cardiologists
|
|
| Locked | Locked | Locked |
AI-based decision support tool for cardiac and pulmonary practices
|
|
| Locked | Locked | Locked |
Develops intravascular MRI catheters for coronary artery applications.
|
|
| Locked | Locked | Locked |
An AI-based cardiac diagnosis tool is provided for healthcare professionals.
|
Detailed competitors of Qianglian Zhichuang
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Qianglian Zhichuang
Complete news archive for Qianglian Zhichuang
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Qianglian Zhichuang
Qianglian Zhichuang was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Qianglian Zhichuang is headquartered in Beijing, China.
Qianglian Zhichuang was founded in 2016 and is based in Beijing, China. AI-driven solutions for cerebrovascular disease diagnosis and treatment are developed, with integrated hardware and software provided for clinical care. Screening, diagnosis, and management of these conditions are supported, along with key decision-making processes. Healthcare professionals are assisted in handling cerebrovascular cases through these tools in the healthcare sector.
Qianglian Zhichuang's top competitors include Saigeware Technologies, Artrya and x-cardiac.
Qianglian Zhichuang has 6 investors. Key investors include Sequoia Capital, Poly Development Holdings, BioTrack Capital, BioVenture, and Sunland Capital.